Ginsenosides in vascular remodeling: Cellular and molecular mechanisms of their therapeutic action

Area of Science:

• Cardiovascular Medicine
• Pharmacology
• Molecular Biology

Background:

• Abnormal vascular remodeling (VR) is a critical precursor to cardiovascular diseases (CVD).
• Current CVD treatments fail to fundamentally reverse VR or restore vascular function.
• Complex signaling networks underlie VR, necessitating novel therapeutic targets.

Purpose of the Study:

• To review the therapeutic effects and mechanisms of ginsenosides in VR-related diseases.
• To provide insights into the intracellular and molecular signaling of ginsenosides in vascular cells.
• To assess the drug development potential of specific ginsenosides (Rb1, Rg1, Rg3).

Main Methods:

• Literature review of studies on ginsenosides and vascular remodeling.
• Analysis of data on ginsenosides' effects on vasodilation, vascular structure, and blood pressure.
• Pharmacodynamic and pharmacokinetic evaluation of ginsenosides for drug development.

Main Results:

• Ginsenosides demonstrate potential to improve VR associated with vasodilation dysfunction, abnormal vascular structure, and hypertension.
• Evidence suggests ginsenosides act on multiple targets and pathways with minimal side effects.
• Specific ginsenosides (Rb1, Rg1, Rg3) show promise for clinical application.

Conclusions:

• Ginsenosides represent a promising therapeutic strategy for targeting vascular remodeling in CVD.
• Further research into ginsenoside signaling pathways can elucidate their mechanisms of action.
• Pharmacological data support the development of ginsenosides as novel CVD therapeutics.